RemovedRisk Factors
Further, while sustainability remains important for our business, views about sustainability are diverse and changing, and our business, reputation and ability to attract and retain clients and employees may be harmed if our actions are perceived to be ineffective, insufficient or otherwise inappropriate. The continuously evolving societal and political perspectives on sustainability make the ultimate impact on us difficult to predict, identify and monitor and may be detrimental to us.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedRisk Factors
reputational damage, financial losses, client dissatisfaction, regulatory enforcement actions, fines and penalties and/or private litigation.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedRisk Factors
The regulatory framework for privacy, data protection and information security worldwide is uncertain, and is likely to remain uncertain for the foreseeable future, and we expect that there will continue to be new laws, rules regulations and industry standards concerning privacy, data protection and information security proposed and enacted in the various jurisdictions in which
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RewordedRisk Factors
The 2022 Share Repurchase Program has no termination date, may be suspended or discontinued at any time and does not obligate the company to acquire any amount of Class A common stock, and In addition, our board of directors may not authorize any increases to or extensions of the 2022 Share Repurchase Program our existing share repurchase programs or any new share repurchase program in the future.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedRisk Factors
At this stage, it is unclear whether This development creates new compliance challenges and when changes has created some uncertainty with respect to the legislation will be adopted and whether such legislative reforms could potentially lead the European Commission to revoke or elect not extend or to revoke further renew the UK adequacy decision.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedRisk Factors
As AI and blockchain are highly complex and rapidly evolving technologies in the early stages of commercial use, there are significant risks involved in the development and use of of, and investment in, AI and blockchain, and there can be no assurance that our development and or use of of, or investment in, AI or blockchain technologies (including potentially for use in digital asset trading in the future) will be successful, gain market acceptance or acceptance, enhance our products or services or augment our business or operating results. results of operations.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedRisk Factors
Also, the EU’s DORA, which will apply was applied as of January 17, 2025, is expected to significantly impact financial subject our EU entities to enhanced governance, compliance and information operational requirements, increased supervisory scrutiny and communications technology service providers. higher costs.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedRisk Factors
Pursuant Both share repurchase programs permit us to the 2022 Share Repurchase Program, the Company may repurchase its shares of Class A common stock from time to time, time at our discretion, in amounts, at prices and at such times as it deems we deem appropriate, subject to market conditions and other considerations.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedRisk Factors
Firms in the financial services industry have experienced increased scrutiny in recent years, and there have been significant penalties, fines and other sanctions sought by governmental and regulatory authorities, including the SEC, the CFTC, the Department of Justice, state securities administrators and state attorneys general in the United States, U.S., the FCA in the UK UK, the AFM in the Netherlands and other foreign regulators, have increased accordingly. regulators.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedRisk Factors
Governmental authorities are likely to continue to issue new laws, rules and regulations governing blockchain technologies. technologies some of which may conflict with each other or with existing obligations under applicable law.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedRisk Factors
While we maintain insurance coverage that is designed to address certain aspects of cyber risks, such insurance coverage may be insufficient to cover all losses or all types of claims that may arise in the event we experience a cybersecurity incident, data breach, disruption, unauthorized access, interruption, significant delay, failure or malfunction in our systems, networks, infrastructure and other operations, affecting, in particular, our platforms platform and solutions, which could result in reputational damage, financial losses, client dissatisfaction, regulatory enforcement actions, fines and penalties and/or private litigation.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedRisk Factors
Payments under the Tax Receivable Agreement are not conditioned on any Continuing LLC Owner’s continued ownership of LLC Interests or our Class A common stock or Class B common stock.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedRisk Factors
If, as a result of industry consolidation, our competitors are able to offer lower cost (including fixed cost fees compared to our variable fees for certain offerings) and/or a wider range of trading venues and solutions, obtain more favorable terms from third-party providers or are otherwise able to take actions that could increase their market share, our competitive position and therefore our business, financial condition and results of operations may be materially adversely affected.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedRisk Factors
Moreover, our AI-related product initiatives and offerings, or our use of AI in our internal business operations, may give rise to risks related to accuracy, reliability, bias, discrimination, harmful content generation, intellectual property infringement, the ability to obtain intellectual property protection, misappropriation or leakage of information, defamation, data privacy and cybersecurity. cybersecurity, including due to the actions of the underlying AI model providers.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedRisk Factors
For example, in 2024, we established offices in Dubai, United Arab Emirates, São Paulo, Brazil, Mumbai, India and Milan, Italy. Italy and in 2025, we opened offices in Bangalore, India and Riyadh, Saudi Arabia.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
We are making significant investments in AI and blockchain products, technologies and companies to, among other things, develop new products and processes or features for our existing products and processes, which is costly.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
If the federal funds rates fall to near-zero levels, the amount of cash held by our corporate clients that is available for investment through the ICD Portal may significantly declines, decline, or if our corporate clients decide to invest their available cash through alternative means, our business, financial condition and results of operations could be adversely affected.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
Any Further, any incident that erodes client loyalty for our brand could significantly reduce its value and damage our business.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
The SEC also has recently adopted amendments to Regulation S-P (the privacy regulation applicable to certain financial institutions, including broker-dealers) that will expand expanded the scope of the regulation and mandate notification to clients and customers in the event of privacy breaches.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
AddedMD&A
In November 2023, we entered into a new market data license agreement with affiliates of LSEG, pursuant to which, among other things, we license certain market data (including real time feeds) for multiple fixed income and derivative products to LSEG which distributes such data directly to LSEG customers through its flagship financial platforms. This agreement was initiated in 2010 with a former owner of the LSEG Data & Analytics business and most recently amended effective November 1, 2025. We primarily earn fixed license fees under the amended market data license agreement, which has an initial 3-year license period through October 31, 2028. The amended market data license agreement is expected to result in higher annual revenue for the year ending December 31, 2026 as compared to the $93.2 million of revenue generated under the market data license agreement in 2025. The majority of the revenue expected to be earned under the amended market data license agreement will be recorded as revenue on a straight-line basis over its initial term ending October 31, 2028, with a portion of such revenue to be recognized when usage occurs based on a revenue share. We will seek to further monetize our data over time both through potential expansion of our existing market data license agreement with LSEG and through distributing additional datasets, derived data and analytics offerings through our own platform or through other third-party networks.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
AddedMD&A
On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the U.S. The OBBBA contains several changes to corporate taxation including modifications to capitalization of research and development expenses, limitations on deductions for interest expense and accelerated fixed asset depreciation. The OBBBA did not have a material impact on the Company’s consolidated statements of financial condition, income or cash flows as of or for the year ended December 31, 2025. The Company will continue to evaluate the implications of this legislation on future periods.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
AddedMD&A
In line with our digital asset strategy, currently included in our other revenue is revenue earned for performing Super Validator and Validator services on the Canton Network (collectively “Validator Revenue”). For these services, we earn Canton Coins and the number of Canton Coins earned in a particular period is variable based on the Canton Network’s minting curve and burn-mint equilibrium and the amount of time that our nodes are active during any given minting cycle (with new rounds beginning at regular 10 minute intervals throughout each day), in comparison to other network participants. Validator Revenue is recognized based on the fair value of each Canton Coin at contract inception, which has been deemed to be the start of each validation round, and therefore Validator Revenue will also vary based on any changes in the fair value of the Canton Coin, which may be highly volatile. As our digital asset strategy continues to evolve, in the future, we may also begin earning revenue from applications developed on the Canton Network.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
AddedMD&A
As of December 31, 2025, we also had $5.0 million in unfunded capital commitments to our equity method investment.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RemovedMD&A
including through the use of data and analytics, we believe the demand for our platforms and electronic trading solutions will continue to grow.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedMD&A
In connection with the acquisition closing, Tradeweb Markets Inc. (the “Corporation”) issued and sold 41,705 shares of Class A common stock, with a grant date fair value of $4.7 million, to an equityholder of the ICD seller, who was also an employee of ICD and is currently an employee of the Company, which shares of Class A common stock were issued and sold as restricted stock (“RSAs”). The RSAs issued are subject to a two-year vesting period and forfeiture terms, pursuant to the Tradeweb Markets Inc. 2019 Omnibus Equity Incentive Plan. Of the $4.7 million in RSAs issued, $3.3 million was allocated to consideration transferred for the business combination, relating to the pre-combination service period completed before the acquisition date, and $1.3 million will be amortized into non-cash stock-based compensation expense over the two-year service period required subsequent to the acquisition date, with such special stock-based compensation amortization expense excluded from our non-GAAP financial measures of Adjusted EBITDA and Adjusted Net Income when it is recorded as expense.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedMD&A
Cash paid at closing, net of cash acquired and net of the proceeds from the sale of the RSAs, totaled $773.8 million, of which $770.9 million was determined to be consideration transferred for the business combination, $1.4 million was expensed during the year ended December 31, 2024 and $1.4 million was recorded as a prepaid asset, to be expensed over a two-year period. Both of these purchase price amounts that were or will be expensed are considered merger and acquisition transaction and integration costs and will be excluded from our non-GAAP financial measures of Adjusted EBITDA and Adjusted Net Income when recorded as expense.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedMD&A
In connection with the ICD Acquisition, we also issued to certain key ICD employees, 92,672 restricted stock units (the “ICD RSU Awards”), with a total grant date fair value of $10.3 million, that will vest one-third each year over a three-year period. Management determined that approximately $5.2 million of the ICD RSU Awards represents market based ordinary course compensation expense for these individuals, with the remaining $5.2 million representing a special award to help ensure retention of these key ICD employees during the three-year period subsequent to the acquisition and allow sufficient time for the integration of ICD’s operations into Tradeweb. The stock-based compensation expense relating to the portion of the ICD RSU Awards determined to be a special award will also be excluded from our non-GAAP financial measures of Adjusted EBITDA and Adjusted Net Income when it is recorded as expense. See “Non-GAAP Financial Measures” below for further details on ICD Acquisition related non-GAAP adjustments.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedMD&A
ICD is an institutional investment technology provider for corporate treasury organizations trading short-term investments. ICD’s flagship products include ICD Portal and ICD Portfolio Analytics. Our ICD portal is a one-stop shop to research, trade, analyze and report on investments across more than 40 available investment providers primarily offering money market funds and access to other short term products including deposits, fixed term funds and separately managed accounts (“SMAs”) (collectively referred to herein as “money market funds”). Portfolio Analytics is an AI-driven cloud solution for aggregating positions across a corporate treasury’s entire portfolio for analysis and reporting.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedMD&A
As part of Tradeweb, our goal is to provide a comprehensive solution for corporate treasurers and asset managers worldwide to manage short-term liquidity needs, including future plans to provide ICD clients with the ability to manage short-term liquidity needs and FX risk, as well as optimize yield and duration via our existing suite of products and partnerships. ICD clients will retain the ability to fully integrate their workflows with leading third-party treasury management and accounting systems and ICD’s portfolio analytics solution. In addition to plans to cross-sell our products to ICD’s clients, we also plan to leverage our international presence with the aim to accelerate growth and expansion, including by offering money market funds to our existing network of clients globally.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedMD&A
On January 19, 2024, we completed our acquisition of r8fin (the “r8fin Acquisition”) in exchange for total consideration of $125.9 million, consisting of $89.2 million in cash paid at closing (net of cash acquired) and the issuance of 374,601 shares of Class A common stock of the Corporation valued as of the acquisition date at $36.7 million.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedMD&A
r8fin provides a suite of algorithmic-based tools as well as a thin-client execution management system (“EMS”) trading application to facilitate futures and cash trades. The solutions complement Tradeweb’s existing Dealerweb Active Streams, Dealerweb Central Limit Order Book (“CLOB”), Tradeweb Request-for-Quote (“RFQ”) and Tradeweb Automated Intelligent Execution (“AiEX”) offerings, creating a valuable and broad-based approach to trading U.S. Treasuries and related futures trading. The r8fin Acquisition is not material to our consolidated financial statements and did not have a significant impact to our results of operations for the year ended December 31, 2024. See Note 4 – Acquisitions to the consolidated financial statements included elsewhere in this Annual Report on Form 10-K for additional details.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedMD&A
On June 20, 2024, we announced organizational changes to optimize operations for continued growth. As part of those organizational changes, Amy Clack joined the Company in August 2024 as Chief Administrative Officer and a member of the Executive Committee, overseeing operations, business integration, risk and corporate services. In addition, Thomas Pluta, our former President, left the Company and the board of directors, effective September 30, 2024. Effective in January 2025, we also named Enrico Bruni and Troy Dixon to the newly created roles of Co-Head of Global Markets. Mr. Dixon stepped down from serving on our board of directors, effective December 31, 2024, in anticipation of his new role as a member of our Executive Committee.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedMD&A
During the year ended December 31, 2024, we incurred $2.9 million in incremental compensation expense related to a cash severance payment to be paid to Mr. Pluta in accordance with the Company’s Executive Severance Policy with respect to Mr. Pluta’s departure in September 2024, all recorded during the three months ended June 30, 2024. As of June 17, 2024, there was also approximately $4.4 million in total unamortized stock-based compensation associated with equity awards previously granted to Mr. Pluta that were accelerated and amortized into expense over a revised estimated service period ending on September 30, 2024. Of this amount, $1.7 million represented regularly scheduled amortization that would have been recognized from June 17, 2024 through September 30, 2024 if Mr. Pluta’s employment was not terminated and $2.7 million represented accelerated stock-based compensation expense that was excluded from our non-GAAP financial measures of Adjusted EBITDA and Adjusted Net Income when it was recorded as expense during the year ended December 31, 2024. See “Non-GAAP Financial Measures” below for further details.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedMD&A
Other loss decreased by $12.0 million to a $1.1 million loss for the year ended December 31, 2024 from a $13.1 million loss for the year ended December 31, 2023. During the year ended December 31, 2024, we recognized a $1.3 million loss due to the impairment of a minority equity investment, which was partially offset by a $0.2 million unrealized gain relating to the increase in fair value of our Canton Coin holdings during the year ended December 31, 2024. During the year ended December 31, 2023, we recognized a $11.1 million loss due to the impairment of a minority equity investment and a $1.3 million loss in connection with unwinding the out-of-the-money foreign currency call option entered into in order to partially mitigate the foreign currency exposure on the payment of the purchase price for the Yieldbroker Acquisition. During the year ended December 31, 2023, we also recognized a $0.7 million loss due to a net reduction in the tax indemnification receivables from Refinitiv relating to the settlement of the tax matter for less than the previously estimated amount.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RemovedMD&A
Current liabilities decreased to $432.9 million as of December 31, 2024 from $659.9 million as of December 31, 2023 primarily due to a decrease in payable to brokers and dealers and clearing organizations resulting from a decrease in unsettled wholesale platform transactions and a lower value of fails to receive, all of which settled in January 2025.
Read it in 10-K Feb 7, 2025 at sec.govopen_in_new
RewordedMD&A
The primary driver of the $387.7 $326.5 million increase in revenue was related to a $345.2 $276.9 million increase in transaction fees and commissions to $1.7 billion for the year ended December 31, 2025 from $1.4 billion for the year ended December 31, 2024 from $1.1 billion for the year ended December 31, 2023, 2024, primarily due to higher revenues for rates derivatives products, U.S. and European corporate bonds, U.S., European and other municipals, U.S government bonds, repurchase agreements international and mortgages, as well as the basis point commissions earned on the ADB of client money market fund investments made through the ICD Portal for the five months in 2024 subsequent to the ICD acquisition closing. U.S.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedMD&A
Revenues from our money markets asset class increased by $52.2 $58.6 million or 82.9% 50.9% to $173.9 million for the year ended December 31, 2025 compared to $115.2 million for the year ended December 31, 2024 compared to $63.0 million for the year ended December 31, 2023 primarily due to the August 1, 2024 acquisition a full year of ICD and the associated basis point commissions earned on the ADB of client money market fund investments made through the ICD Portal, Portal during the year ended December 31, 2025 compared to five months during the year ended December 31, 2024 for the period subsequent to the August 1, 2024 acquisition, as well as higher variable transaction fees and commissions on higher trading volumes for repurchase agreements.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedMD&A
Revenues from International international clients increased by $177.4 $193.1 million or 36.4% 29.0% to $858.4 million for the year ended December 31, 2025 compared to $665.3 million for the year ended December 31, 2024 from $487.9 million for the year ended December 31, 2023 primarily due to higher revenues for rates derivatives products, European and other government bonds, European corporate bonds, market data and money markets, including contributions the contribution from ICD. the ICD acquisition, market data, European government bonds, international ETFs and European corporate bonds.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedMD&A
Revenues from U.S. clients increased by $210.4 $133.4 million or 24.7% 12.6% to $1.2 billion for the year ended December 31, 2025 compared to $1.1 billion for the year ended December 31, 2024 from $850.3 million for the year ended December 31, 2023 primarily due to higher revenues for U.S. corporate bonds, money markets, including the contribution from the ICD acquisition, rates derivatives products, municipals, U.S. government bonds, rates derivatives products, market data mortgages and money markets, including contributions from ICD. U.S.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedMD&A
Net cash used in financing activities for the year ended December 31, 2023 2025 was $168.2 $307.5 million, and was primarily driven by $75.9 which consisted of $104.2 million in share repurchases pursuant to our 2022 Share Repurchase Program, $102.3 million in cash dividends to our Class A and Class B common stockholders, $36.1 $49.5 million in payroll tax payments for options, PRSUs and RSUs, net of proceeds from stock-based compensation option exercises, $35.2 $26.7 million in share repurchases pursuant to payments made under our 2022 Share Repurchase Program Tax Receivable Agreement and $12.4 $24.7 million in distributions to non-controlling interest holders.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedMD&A
Excluding cash paid at closing for acquisitions, we We expect total cash paid for capital expenditures and software development costs for fiscal year 2025 2026 to be between $99 $107 million and $109 $117 million, compared to expenditures of $88.9 $103.1 million and $61.8 $88.9 million in fiscal years 2024 2025 and 2023, 2024, respectively, with the midpoint of our 2025 2026 capital expenditure guidance up 17% approximately 9% versus fiscal year 2024 2025 primarily due driven by platform enhancements, infrastructure modernization and cyber security initiatives to anticipated capitalized spend associated with our global headquarters relocation. support long-term growth.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedMD&A
December 31, 2025 2024 2023 (dollars in thousands) Cash and cash equivalents $ 2,084,739 $ 1,340,302 $ 1,706,468 Restricted cash 1,000 1,000 Receivable from brokers and dealers and clearing organizations 8,630 67,805 381,178 Deposits with clearing organizations 58,282 54,702 36,806 Accounts receivable 257,845 222,268 168,407 Receivable and due from affiliates related parties 8,303 8,094 192 Current portion of other assets 71,239 43,163 Total current assets 1,694,171 2,294,051 Securities sold under agreements to repurchase — 21,612 2,490,038 1,737,334 Payable to brokers and dealers and clearing organizations 3,363 67,816 351,864 Accrued compensation 251,169 222,959 164,329 Deferred revenue 29,030 30,800 25,746 Payable and due to affiliates related parties 7,090 763 1,327 Current portion of:
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedMD&A
Revenues from our corporates client sector primarily includes The primary driver of the increase was a full year of basis point commissions earned on the ADB of client money market fund investments made through the ICD Portal during the year ended December 31, 2025 compared to five months during the year ended December 31, 2024 for the five months period subsequent to the acquisition closing. August 1, 2024 acquisition.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedMD&A
The increase was primarily due to increases in amortization of assets acquired in connection with the ICD, r8fin and Yieldbroker acquisitions ICD acquisition on August 1, 2024, January 19, 2024 and August 31, 2023, respectively. increases in amortization of software development costs and hardware driven by increases in investment in our infrastructure and the relocation of our New York City corporate headquarters during September 2025.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedMD&A
Net cash provided by operating activities for the year ended December 31, 2024 2025 was $897.7 million, $1.2 billion, an increase of $151.7 $269.9 million as compared to the year ended December 31, 2023, 2024, primarily driven by an increase in net income income, a decrease in cash paid for taxes due to changes in the timing of tax payments year over year and other net changes in working capital, partially offset by an increase in cash paid for income taxes. capital.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedMD&A
Interest income increased decreased by $6.6 $5.6 million to $68.4 million for the year ended December 31, 2025 from $74.0 million for the year ended December 31, 2024 from $67.4 million for the year ended December 31, 2023 primarily due to increases a decrease in the average interest rates and our average invested cash balance period over period. earned period-over-period.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
RewordedMD&A
Year Ended December 31, 2025 2024 2023 2022 (dollars in thousands, except per share amounts) Earnings per diluted share $ 3.78 $ 2.33 $ 1.71 $ 1.48 Net income attributable to Tradeweb Markets Inc. $ 812,792 $ 501,507 $ 364,866 $ 309,338 Net income attributable to non-controlling interests (1) 108,708 68,456 54,637 50,275 Net income 921,500 569,963 419,503 359,613 Provision for income taxes 253,474 184,439 128,477 77,520 Merger and acquisition transaction and integration costs (2) 6,891 22,823 8,042 1,069 D&A related to acquisitions and the Refinitiv Transaction (3) 176,322 156,489 127,731 126,659 Stock-based compensation expense (4) 2,327 6,096 2,947 20,409 Foreign exchange (gains) / losses (5) 13,112 (6,326) (47) 4,409 Tax receivable agreement liability adjustment (6) (9,786) (7,730) 9,517 (13,653) Other (income) loss, net (263,384) 1,114 13,122 1,000 Adjusted Net Income before income taxes 1,100,456 926,868 709,292 577,026 Adjusted income taxes (7) (275,114) (231,717) (173,777) (126,946) Adjusted Net Income $ 825,342 $ 695,151 $ 535,515 $ 450,080 Adjusted Diluted EPS (8) $ 3.47 $ 2.92 $ 2.26 $ 1.90
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
Quiet changesMD&A
The impact of any changes in the legal or regulatory landscape on us and our operations generally remains uncertain.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new
Quiet changesMD&A
Other income (loss), net consists of any income or loss earned from investments, any mark-to-market adjustments or impairments recorded on investments, any unrealized and realized gain/loss on foreign exchange derivative contracts entered into for foreign exchange risk management purposes relating to investing activities and any other non-operating items.
Read it in 10-K Feb 5, 2026 at sec.govopen_in_new